1. Home
  2. TGTX
  3. TGTX News

Latest TG Therapeutics Inc. (TGTX) News on April 2, 2025

Should We Be Cautious About TG Therapeutics, Inc.'s (NASDAQ:TGTX) ROE Of 11%?
TGTX

Simply Wall St.

3 days ago

Should We Be Cautious About TG Therapeutics, Inc.'s (NASDAQ:TGTX) ROE Of 11%?

TGTX

Argus Research

7 days ago

TGTX: Raising target price to $45.00

These Insurance Stocks And Biotech Leader Hit New Highs As Stock Market Crumbles
TGTX

Investor's Business Daily

12 days ago

These Insurance Stocks And Biotech Leader Hit New Highs As Stock Market Crumbles

TG Therapeutics (TGTX): Among the Best Short Squeeze Stocks to Buy According to Analysts
TGTX

Insider Monkey

14 days ago

TG Therapeutics (TGTX): Among the Best Short Squeeze Stocks to Buy According to Analysts

Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength?
TGTX

Zacks

16 days ago

Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength?

Is TG Therapeutics, Inc. (TGTX) the Best Performing Growth Stock in 2025?
TGTX

Insider Monkey

19 days ago

Is TG Therapeutics, Inc. (TGTX) the Best Performing Growth Stock in 2025?

Biotech Stock TG Therapeutics Hits A High In Market Meltdown
TGTX

Investor's Business Daily

22 days ago

Biotech Stock TG Therapeutics Hits A High In Market Meltdown

TG Therapeutics (NasdaqCM:TGTX) Surges 28% Following US$23 Million Net Income Turnaround
TGTX

Simply Wall St.

23 days ago

TG Therapeutics (NasdaqCM:TGTX) Surges 28% Following US$23 Million Net Income Turnaround

S&P 500 Pair, Warren Buffet Pick Lead Five Stocks Near Buy Points Amid Market Shakeout
TGTX

Investor's Business Daily

25 days ago

S&P 500 Pair, Warren Buffet Pick Lead Five Stocks Near Buy Points Amid Market Shakeout

Why TG Therapeutics Stock Was Soaring This Week
TGTX

Motley Fool

25 days ago

Why TG Therapeutics Stock Was Soaring This Week

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
TGTX

GlobeNewswire

a month ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

This Biotech Stock Hits Buy Point After Earnings Burst
TGTX

Investor's Business Daily

a month ago

This Biotech Stock Hits Buy Point After Earnings Burst

TGTX

Argus Research

a month ago

TGTX: Raising target price to $37.00

TGTX

MT Newswires

a month ago

B. Riley Raises Price Target on TG Therapeutics to $53 From $38, Keeps Buy Rating

Exploring 3 High Growth Tech Stocks In The US Market
TGTX

Simply Wall St.

a month ago

Exploring 3 High Growth Tech Stocks In The US Market

Why TG Therapeutics, Inc. (TGTX) Surged On Monday?
TGTX

Insider Monkey

a month ago

Why TG Therapeutics, Inc. (TGTX) Surged On Monday?

Company News for Mar 4, 2025
TGTX

Zacks

a month ago

Company News for Mar 4, 2025

TG Therapeutics Inc (TGTX) Q4 2024 Earnings Call Highlights: Strong U.S. ...
TGTX

GuruFocus.com

a month ago

TG Therapeutics Inc (TGTX) Q4 2024 Earnings Call Highlights: Strong U.S. ...

TGTX

Thomson Reuters StreetEvents

a month ago

Q4 2024 TG Therapeutics Inc Earnings Call

TG Therapeutics soared 17% after earnings surprise
TGTX

TheStreet

a month ago

TG Therapeutics soared 17% after earnings surprise

TG Therapeutics, A New Leaderboard Stock, Skyrockets 14% On Sales Beat, Bullish Guide
TGTX

Investor's Business Daily

a month ago

TG Therapeutics, A New Leaderboard Stock, Skyrockets 14% On Sales Beat, Bullish Guide

TGTX

Associated Press Finance

a month ago

TG Therapeutics: Q4 Earnings Snapshot

TGTX

MT Newswires

a month ago

TG Therapeutics Swings to Q4 Net Income, Revenue Rises; 2025 Revenue Guidance Set

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
TGTX

GlobeNewswire

a month ago

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
TGTX

GlobeNewswire

a month ago

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update
TGTX

GlobeNewswire

a month ago

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update

TGTX

Argus Research

a month ago

TGTX: Lowering target price to $31.00

Institutional investors in TG Therapeutics, Inc. (NASDAQ:TGTX) see US$243m decrease in market cap last week, although long-term gains have benefitted them.
TGTX

Simply Wall St.

a month ago

Institutional investors in TG Therapeutics, Inc. (NASDAQ:TGTX) see US$243m decrease in market cap last week, although long-term gains have benefitted them.

TGTX

Argus Research

a month ago

TGTX: What does Argus have to say about TGTX?

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
TGTX

GlobeNewswire

a month ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

How Small, But 'Mighty' TG Therapeutics Scored A 470% Gain Over 13 Months
TGTX

Investor's Business Daily

2 months ago

How Small, But 'Mighty' TG Therapeutics Scored A 470% Gain Over 13 Months

TGTX

MT Newswires

2 months ago

MaxCyte Licenses Cell-Engineering Technology to TG Therapeutics

TGTX

Argus Research

2 months ago

TGTX: What does Argus have to say about TGTX?

TGTX

Argus Research

2 months ago

TGTX: Raising target price to $35.00

All You Need to Know About TG Therapeutics (TGTX) Rating Upgrade to Buy
TGTX

Zacks

2 months ago

All You Need to Know About TG Therapeutics (TGTX) Rating Upgrade to Buy

TGTX

Argus Research

2 months ago

TGTX: What does Argus have to say about TGTX?

Here’s Why Analysts Are Bullish on TG Therapeutics, Inc. (TGTX)
TGTX

Insider Monkey

2 months ago

Here’s Why Analysts Are Bullish on TG Therapeutics, Inc. (TGTX)

Exploring Three High Growth Tech Stocks In The United States
TGTX

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks In The United States

Is TG Therapeutics Inc. (TGTX) Among Tuesday’s Top Gainers?
TGTX

Insider Monkey

3 months ago

Is TG Therapeutics Inc. (TGTX) Among Tuesday’s Top Gainers?

TGTX Announces 2024 Preliminary Results, 2025 Goals, Shares Rise
TGTX

Zacks

3 months ago

TGTX Announces 2024 Preliminary Results, 2025 Goals, Shares Rise

TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?
TGTX

Zacks

3 months ago

TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?

TGTX

Argus Research

3 months ago

TGTX: Raising target price to $31.00

Why TGTX Stock Is Rallying Today
TGTX

Insider Monkey

3 months ago

Why TGTX Stock Is Rallying Today

TGTX

MT Newswires

3 months ago

TG Therapeutics Provides Q4 Briumvi Revenue Guidance; Sets 2025 Total Revenue Outlook; Shares Rise Pre-Bell

TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones
TGTX

GlobeNewswire

3 months ago

TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones

Should You Invest in TG Therapeutics (TGTX)?
TGTX

Insider Monkey

3 months ago

Should You Invest in TG Therapeutics (TGTX)?

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
TGTX

GlobeNewswire

3 months ago

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

TG Therapeutics price target raised to $10 from $9 at BofA
TGTX

TipRanks

3 months ago

TG Therapeutics price target raised to $10 from $9 at BofA

TGTX

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 01/08/2025

TGTX

MT Newswires

3 months ago

--BofA Securities Adjusts Price Target on TG Therapeutics to $10 From $9, Maintains Underperform Rating

Will TG Therapeutics, Inc. (TGTX) Make You Rich In 2025?
TGTX

Insider Monkey

3 months ago

Will TG Therapeutics, Inc. (TGTX) Make You Rich In 2025?

TGTX

Argus Research

3 months ago

TGTX: Lowering target price to $34.00

TGTX

Argus Research

3 months ago

TGTX: Raising target price to $35.00

High Growth Tech Stocks To Watch In The United States
TGTX

Simply Wall St.

4 months ago

High Growth Tech Stocks To Watch In The United States

TGTX

Argus Research

4 months ago

TGTX: Lowering target price to $33.00

TGTX

Argus Research

4 months ago

TGTX: Lowering target price to $35.00

TG Therapeutics to Participate in the Evercore HealthCONx Conference
TGTX

GlobeNewswire

4 months ago

TG Therapeutics to Participate in the Evercore HealthCONx Conference

TG Therapeutics price target raised to $43 from $30 at JPMorgan
TGTX

TipRanks

4 months ago

TG Therapeutics price target raised to $43 from $30 at JPMorgan

TG Therapeutics Stock Soars Nearly 15% After Topping Deloitte's Fast 500 and Raising Revenue Outlook
TGTX

GuruFocus.com

4 months ago

TG Therapeutics Stock Soars Nearly 15% After Topping Deloitte's Fast 500 and Raising Revenue Outlook

TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
TGTX

GlobeNewswire

4 months ago

TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

TGTX

Argus Research

5 months ago

TGTX: Raising target price to $32.00

Exploring 3 High Growth Tech Stocks in the United States
TGTX

Simply Wall St.

5 months ago

Exploring 3 High Growth Tech Stocks in the United States

TG Therapeutics, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
TGTX

Simply Wall St.

5 months ago

TG Therapeutics, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

TGTX

Argus Research

5 months ago

TGTX: Rating decreased to a HOLD

TG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
TGTX

Simply Wall St.

5 months ago

TG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
TGTX

GuruFocus.com

5 months ago

TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

TGTX

Thomson Reuters StreetEvents

5 months ago

Q3 2024 TG Therapeutics Inc Earnings Call

TG Therapeutics Crashes — Reversing A Breakout — After Missing 'Whisper' Expectations
TGTX

Investor's Business Daily

5 months ago

TG Therapeutics Crashes — Reversing A Breakout — After Missing 'Whisper' Expectations

TGTX

MT Newswires

5 months ago

Sector Update: Health Care Stocks Mixed Premarket Monday

TG Therapeutics (TGTX) Lags Q3 Earnings Estimates
TGTX

Zacks

5 months ago

TG Therapeutics (TGTX) Lags Q3 Earnings Estimates

AI Stocks Meta, Oracle Lead Five Names Near Buy Points
TGTX

Investor's Business Daily

5 months ago

AI Stocks Meta, Oracle Lead Five Names Near Buy Points

TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update
TGTX

GlobeNewswire

5 months ago

TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update

Is TG Therapeutics, Inc. (TGTX) Set to Explode in 2025?
TGTX

Insider Monkey

5 months ago

Is TG Therapeutics, Inc. (TGTX) Set to Explode in 2025?

High Growth Tech Stocks to Watch in October 2024
TGTX

Simply Wall St.

6 months ago

High Growth Tech Stocks to Watch in October 2024

TGTX

Argus Research

6 months ago

TGTX: Lowering target price to $23.00

TG Therapeutics Inc (TGTX): Short Seller Sentiment is Bearish
TGTX

Insider Monkey

6 months ago

TG Therapeutics Inc (TGTX): Short Seller Sentiment is Bearish

Are Robust Financials Driving The Recent Rally In TG Therapeutics, Inc.'s (NASDAQ:TGTX) Stock?
TGTX

Simply Wall St.

6 months ago

Are Robust Financials Driving The Recent Rally In TG Therapeutics, Inc.'s (NASDAQ:TGTX) Stock?

Stocks Reverse Lower After Fed's Half-Point Rate Cut; Donald Trump Stock Slammed Again (Live Coverage)
TGTX

Investor's Business Daily

6 months ago

Stocks Reverse Lower After Fed's Half-Point Rate Cut; Donald Trump Stock Slammed Again (Live Coverage)

TGTX

MT Newswires

6 months ago

Sector Update: Health Care Stocks Steady Premarket Wednesday

IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug
TGTX

Investor's Business Daily

6 months ago

IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug

TGTX

MT Newswires

6 months ago

TG Therapeutics Reports 30-Minute BRIUMVI Infusions Well Tolerated in Relapsing Multiple Sclerosis Trial

New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis
TGTX

GlobeNewswire

6 months ago

New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis

New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment
TGTX

GlobeNewswire

6 months ago

New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
TGTX

PR Newswire

7 months ago

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Four Biotech Stocks Rally Toward Buy Points As Funds Load Up
TGTX

Investor's Business Daily

7 months ago

Four Biotech Stocks Rally Toward Buy Points As Funds Load Up

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
TGTX

GlobeNewswire

7 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

TG Therapeutics Inc (NASDAQ:TGTX) A Bull Case Theory
TGTX

Insider Monkey

7 months ago

TG Therapeutics Inc (NASDAQ:TGTX) A Bull Case Theory

High Growth Tech Stocks in the United States to Watch
TGTX

Simply Wall St.

7 months ago

High Growth Tech Stocks in the United States to Watch

IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter
TGTX

Investor's Business Daily

7 months ago

IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter

IBD Stock Of The Day TG Therapeutics Flirts With Two Breakouts On Its Newfound Profitability
TGTX

Investor's Business Daily

8 months ago

IBD Stock Of The Day TG Therapeutics Flirts With Two Breakouts On Its Newfound Profitability

FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment
TGTX

Clinical Trials Arena

8 months ago

FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment

Results: TG Therapeutics, Inc. Confounded Analyst Expectations With A Surprise Profit
TGTX

Simply Wall St.

8 months ago

Results: TG Therapeutics, Inc. Confounded Analyst Expectations With A Surprise Profit

TGTX

MT Newswires

8 months ago

B. Riley Adjusts Target on TG Therapeutics to $34 From $29, Maintains Buy Rating

TG Therapeutics Stock Rockets As Surprise Profit Smashes Views By 157%
TGTX

Investor's Business Daily

8 months ago

TG Therapeutics Stock Rockets As Surprise Profit Smashes Views By 157%

TGTX

MT Newswires

8 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

TGTX

MT Newswires

8 months ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

TGTX

MT Newswires

8 months ago

Sector Update: Health Care

TGTX

MT Newswires

8 months ago

TG Therapeutics Shares Rally After Swinging to Surprise Q2 Profit, Revenue Surges; Boosts Full-Year Outlook for Briumvi Sales

TG Therapeutics Stock Jumps As Surprise Profit Smashes Views By 157%
TGTX

Investor's Business Daily

8 months ago

TG Therapeutics Stock Jumps As Surprise Profit Smashes Views By 157%

TG Therapeutics (TGTX) Surpasses Q2 Earnings and Revenue Estimates
TGTX

Zacks

8 months ago

TG Therapeutics (TGTX) Surpasses Q2 Earnings and Revenue Estimates

Share on Social Networks: